Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Shivam Patel

Physician Assistant Boston, MA Physician Assistant

NPI 1710584222 CMS profile 11254167

75 Francis St, Boston, MA 02115

Open in the dashboard

General payments

$1,426

60 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shivam Patel of Boston, MA is reported in the CMS Open Payments database as having received $1,426 across 60 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 74th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $187 2
2022 General $1,034 49
2021 General $204 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shivam Patel
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Shivam Patel were reported at $187. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Shivam Patel Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $204 $132 $37–$438 $132
2022 $1,034 $155 $48–$522 $149
2023 $0 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $187 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $269 9 payments
  2. Lilly USA, LLC $223 15 payments
  3. Salix Pharmaceuticals, a division of Bausch Health US, LLC $222 11 payments
  4. AbbVie, Inc. $216 3 payments
  5. Alkermes, Inc. $209 10 payments
  6. RedHill Biopharma Inc. $120 7 payments
  7. Gilead Sciences, Inc. $92 1 payment
  8. GRT US Holding, Inc. $21 1 payment
  9. Almatica Pharma LLC $21 1 payment
  10. Nalu Medical, Inc. $17 1 payment
  11. Other $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,421 59 payments
  2. Education $5 1 payment
Products named General payments · program years 2021–2025
  1. WaveWriter Alpha Prime 16 $269 9 payments
  2. EMGALITY $223 15 payments
  3. RELISTOR Gastroenterology $222 11 payments
  4. RELISTOR Gastroenterology $222 11 payments
  5. VIVITROL $209 10 payments
  6. REYVOW $132 8 payments
  7. CREON $131 1 payment
  8. Movantik $120 7 payments
  9. Epclusa $92 1 payment
  10. JARDIANCE $91 7 payments
  11. Other $145 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

429

Median for Physician Assistant: 241

Drug cost

$479,434

Median for Physician Assistant: $4,110

Branded share of claims

36.6%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Creon Lipase/Protease/Amylase Brand 78 $326,751
Zenpep Lipase/Protease/Amylase Brand 20 $115,130
Linzess Linaclotide Brand 30 $21,469
Trulance Plecanatide Brand 11 $9,770
Omeprazole Generic 124 $2,272
Esomeprazole Magnesium Generic 18 $1,063
Famotidine Generic 64 $973
Colestipol Hcl Generic 12 $661
Pantoprazole Sodium Generic 36 $594
Loperamide Loperamide Hcl Brand 18 $508

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 5 billing codes

Paid by Medicare

$15,932

Medicare's payments for the services billed

Medicare patients

118

Average age 72

Services billed

162

88 women, 30 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 53%
Ischemic heart disease 33%
Depression 30%
Osteoporosis 30%
Diabetes 27%
Chronic kidney disease 27%
Atrial fibrillation 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

60 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record